TC
FLGT icon

TwinBeech Capital’s Fulgent Genetics FLGT Stock Holding History

TwinBeech Capital’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-7,418
Closed -$463K – 572
2022
Q1 		$463K Buy
+7,418
New +$488K 0.02% 396
2021
Q2 		– Sell
-2,250
Closed -$217K – 510
2021
Q1 		$217K Buy
+2,250
New +$232K 0.03% 420

Other funds holding FLGT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

TwinBeech Capital's FLGT Position: Q2 2022 in Review

TwinBeech Capital sold out of Fulgent Genetics (FLGT) in Q2 2022, closing a stake of 7,418 shares — an estimated $463K sold.

TwinBeech Capital first reported a position in FLGT in Q1 2021 and held it in 2 quarters. The position peaked at $463K in Q1 2022. 262 funds tracked by Wall St. Rank hold FLGT as of Q2 2022.

  • TwinBeech Capital reported no remaining Fulgent Genetics position as of Q2 2022 after selling out during the quarter.
  • TwinBeech Capital sold 7,418 Fulgent Genetics shares in Q2 2022, an estimated $463K.
  • TwinBeech Capital first reported a position in Fulgent Genetics in Q1 2021 and held it in 2 quarters.
  • TwinBeech Capital's Fulgent Genetics position peaked at $463K in Q1 2022.
  • 262 funds tracked by Wall St. Rank held Fulgent Genetics as of Q2 2022.

Based on TwinBeech Capital's 13F filing for Q2 2022, filed 15 Aug 2022.